Jupiter Neurosciences, Inc.
JUNS
$1.21
$0.032.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -466.30% | -133.70% | 9.16% | 49.00% | -- |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 3,181.00% | 2,240.00% | 1,309.50% | 489.76% | -- |
| Total Other Non-Cash Items | 5,016.53% | 772.72% | -15.32% | -48.58% | -- |
| Change in Net Operating Assets | -384.20% | -239.37% | -250.15% | -209.26% | -- |
| Cash from Operations | -1,691.05% | -1,032.72% | -996.96% | -713.12% | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -99.44% | -93.20% | -77.20% | -64.49% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 100.00% | 100.00% | 400.00% | 172.73% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,254.89% | 1,448.14% | 1,628.86% | 1,619.55% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,318.18% | 14,434.62% | 36,076.00% | 10,491.67% | -- |